Web Stats Provided By Google Analytics

Wednesday, April 2, 2014

Janssen Seeks Approval for Combination HIV Therapy

Janssen Research & Development has submitted a new drug application to the FDA for a once-daily fixed-dose antiretroviral combination tablet containing Prezista and cobicistat .

http://ift.tt/1mAHGaK
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)